Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses

References

• Kishore P, Kim SH, Crandall JP. Glycemic control and cardiovascular disease: what’s a doctor to do? Curr Diab Rep. 2012;12:255–264. doi:10.1007/s11892-012-0268-5
   PubMed Web of Science ®Google Scholar
• La Sala L, Prattichizzo F, Ceriello A. The link between diabetes and atherosclerosis. Eur J Prev Cardiol. 2019;26:15–24. doi:10.1177/2047487319878373
   PubMed Web of Science ®Google Scholar
• Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008;9:465–476. doi:10.1038/nrg2341
   PubMed Web of Science ®Google Scholar
• Kim M. DNA methylation: a cause and consequence of type 2 diabetes. Genomics Inform. 2019;17(4):e38. doi:10.5808/GI.2019.17.4.e38
   PubMedGoogle Scholar
• Nilsson E, Jansson PA, Perfilyev A, et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes. 2014;63(9):2962–2976. doi:10.2337/db13-1459
   PubMed Web of Science ®Google Scholar
• Olsson AH, Volkov P, Bacos K, et al. Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet. 2014;10:e1004735. doi:10.1371/journal.pgen.1004735
   PubMed Web of Science ®Google Scholar
• Scisciola L, Rizzo MR, Marfella R, et al. New insight in molecular mechanisms regulating SIRT6 expression in diabetes: hyperglycaemia effects on SIRT6 DNA methylation. J Cell Physiol. 2021;236(6):4604–4613. doi:10.1002/jcp.30185
   PubMed Web of Science ®Google Scholar
• Jiang YZ, Jiménez JM, Kristy O, et al. Hemodynamic disturbed flow induces differential DNA methylation of endothelial Kruppel-like factor 4 promoter in vitro and in vivo. Circ Res. 2014;115(1):32–43. doi:10.1161/CIRCRESAHA.115.303883
   PubMed Web of Science ®Google Scholar
• Scisciola L, Rizzo MR, Cataldo V, et al. Incretin drugs effect on epigenetic machinery: new potential therapeutic implications in preventing vascular diabetic complications. FASEB J. 2020;34(12):16489–16503. doi:10.1096/fj.202000860RR
   PubMed Web of Science ®Google Scholar
• Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–1381. doi:10.1152/physrev.00058.2009
   PubMed Web of Science ®Google Scholar
• Rosen ED, Kaestner KH, Natarajan R, et al. Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes. 2018;67(10):1923–1931. doi:10.2337/db18-0537
   PubMed Web of Science ®Google Scholar
• Pan L, Li Z, Wang Y, Zhang B, Liu G, Liu J. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus. J Ethnopharmacol. 2020;258:112842. doi:10.1016/j.jep
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang W, Xuan -L-L, et al. Akebia saponin D inhibits the formation of atherosclerosis in ApoE−/− mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis. 2019;285:23–30. doi:10.1016/j.atherosclerosis.2019.04.202
   PubMed Web of Science ®Google Scholar
• Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol Biol. 2007;396:71–91.
   PubMedGoogle Scholar
• Cecilia C, Wang L. Clinical update: cardiovascular disease in diabetes mellitus. Circulation. 2016;133(24):2459–2502. doi:10.1161/CIRCULATIONAHA.116.022194
   PubMed Web of Science ®Google Scholar
• Zhu Q, Kang J, Xu G. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: study protocol for a randomized controlled multicenter trial. Medicine. 2020;99(11):e19501. doi:10.1097/MD.0000000000019501
   PubMed Web of Science ®Google Scholar
• Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes. 2003;52:1256–1264. doi:10.2337/diabetes.52.5.1256
   PubMed Web of Science ®Google Scholar
• Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008;371:1800–1809. doi:10.1016/S0140-6736(08)60768-0
   PubMed Web of Science ®Google Scholar
• Jia Z, Jing C, Qian Z, Xinhua X. Novel insights into DNA methylation and its critical implications in diabetic vascular complications. Bioscience Rep. 2017;39(2):BSR20160611. doi:10.1042/BSR20160611
   Web of Science ®Google Scholar
• Pang M, Li Y, Gu W, Sun Z, Wang Z, Li L. Recent advances in epigenetics of macrovascular complications in diabetes mellitus. Heart Lung Circ. 2020;30(2):186–196. doi:10.1016/j.hlc.2020.07.015
   PubMed Web of Science ®Google Scholar
• Dayeh T, Volkov P, Salo S, et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014;10(3):e1004160. doi:10.1371/journal.pgen.1004160
   PubMed Web of Science ®Google Scholar
• Makki N, Thiel KW, Miller FJ Jr. The epidermal growth factor receptor and its ligands in cardiovascular disease. Int J Mol Sci. 2013;14:20597–20613. doi:10.3390/ijms141020597
   PubMed Web of Science ®Google Scholar
• Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis. 2006;186:38–53. doi:10.1016/j.atherosclerosis.2005.06.038
   PubMed Web of Science ®Google Scholar
• Mindur JE, Swirski FK. Growth factors as immunotherapeutic targets in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2019;39(7):1275–1287. doi:10.1161/ATVBAHA.119.311994
   PubMed Web of Science ®Google Scholar
• Karadoğan AH, Arikoglu H, Göktürk F, Işçioğlu F, Ipekçi SH. PIK3R1 gene polymorphisms are associated with type 2 diabetes and related features in the Turkish population. Adv Clin Exp Med. 2018;27(7):921–927. doi:10.17219/acem/68985
   PubMed Web of Science ®Google Scholar
• Fernandez-Hernando C, Jozsef L, Jenkins D. Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:2033–2040. doi:10.1161/ATVBAHA.109.196394
   PubMed Web of Science ®Google Scholar
• Fernandez-Hernando C, Ackah E, Yu J, et al. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 2007;6:446–457. doi:10.1016/j.cmet.2007.10.007
   PubMed Web of Science ®Google Scholar
• Rotllan N, Wanschel AC, Fernandez-Hernando A, et al. Genetic evidence supports a major role for Akt1 in VSMCs during atherogenesis. Circ Res. 2015;116:1744–1752. doi:10.1161/CIRCRESAHA.116.305895
   PubMed Web of Science ®Google Scholar
• Chen L, Zheng S-Y, Yang C-Q, Ma B-M, Jiang D. MiR-155-5p inhibits the proliferation and migration of VSMCs and HUVECs in atherosclerosis by targeting AKT1. Eur Rev Med Pharmacol Sci. 2019;23:2223–2233. doi:10.26355/eurrev_201903_17270
   PubMed Web of Science ®Google Scholar
• Furuhashi M, Tuncman G, Gorgun CZ. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959–965. doi:10.1038/nature05844
   PubMed Web of Science ®Google Scholar
• Chow WS, Tso AW, Xu A, et al. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc. 2013;2(1):e004176. doi:10.1161/JAHA.112.004176
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Johnson RS, Distel RJ, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274(5291):1377–1379. doi:10.1126/science.274.5291.1377
   PubMed Web of Science ®Google Scholar
• Heuser M, Yun H, Thol F. Epigenetics in myelodysplastic syndromes. Semin Cancer Biol. 2018;51:170–179. doi:10.1016/j.semcancer.2017.07.009
   PubMed Web of Science ®Google Scholar